Transferable trimethoprim resistance of shigellae encountered in Vellore (south India)

Insights

Shigella bacteria in South India show high resistance to trimethoprim and trimethoprim-sulfamethoxazole. This drug resistance is primarily spread through plasmids, according to transfer studies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Shigella species are significant causes of bacterial dysentery worldwide.
  • Antimicrobial resistance in Shigella poses a major public health challenge, particularly in developing regions.
  • Trimethoprim and trimethoprim-sulfamethoxazole are commonly used antibiotics for treating Shigella infections.

Purpose of the Study:

  • To investigate the prevalence and mechanisms of trimethoprim and trimethoprim-sulfamethoxazole resistance in Shigella flexneri and Shigella shigae strains.
  • To determine if high-level resistance observed in these strains is transferable and plasmid-mediated.

Main Methods:

  • Clinical isolates of Shigella flexneri and Shigella shigae from Vellore, South India were screened for antibiotic susceptibility.
  • Minimum Inhibitory Concentrations (MICs) were determined for trimethoprim and trimethoprim-sulfamethoxazole.
  • Plasmid transfer experiments (conjugation) were performed using resistant strains as donors and susceptible strains as recipients.

Main Results:

  • A high prevalence of resistance to trimethoprim and trimethoprim-sulfamethoxazole was observed in the studied Shigella strains.
  • Eighty-four percent of the resistant isolates exhibited high-level resistance.
  • Plasmid transfer studies confirmed that high-level trimethoprim resistance is transferable, indicating a plasmid-mediated mechanism.

Conclusions:

  • Shigella flexneri and Shigella shigae in Vellore exhibit significant high-level resistance to trimethoprim and trimethoprim-sulfamethoxazole.
  • The resistance is largely plasmid-mediated, suggesting potential for further dissemination.
  • These findings highlight the urgent need for monitoring and alternative therapeutic strategies against Shigella infections in the region.

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...